M&A TRANSACTION · 2020
NN Life Sciences (Paragon Medical) acquired by American Securities
$825.0M· 12.5x EBITDA· 2.40x revenue
Target
NN Life Sciences (Paragon Medical)
Acquirer
American Securities
Private Equity buyer
Disclosed financials at time of acquisition
Revenue
$338.8M
EBITDA
$66.0M
Deal Value
$825.0M
EV/EBITDA
12.5x
Context
This $825.0M acquisition of NN Life Sciences (Paragon Medical) by American Securities sits in the medical devices sub-vertical. The 12.5x EBITDA multiple paid in 2020 can be compared against the population median for medical devices transactions of similar size on our Medical Devices valuation hub. American Securities is acquiring as a private equity buyer; see how PE acquirers typically price medical devices businesses on our Medical Devices PE buyer-pool page.
Source
Data sourced from Press releases and investor presentations. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own medical devices
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Compare your business to the NN Life Sciences (Paragon Medical) acquisition.